Minerva Neurosciences NERV Stock Price vs Value Analysis Minerva Neurosciences posts 1092 EPS miss wider loss vs estimates Industrial Select Sector SPDR Fund XLI Comparative Performance and Thematic Fit Across US Reshoring ETFs iShares 20 Year Treasury Bond ETF TLT Navigating RateCut Cycles Strategic Positioning in Fixed Income Real Estate and Housing NRXP NRX Pharmaceuticals shares climb 352 percent as investors shrug off worse than expected Q4 2025 EPS miss